Sun Pharma soars on entering into license agreement with AstraZeneca UK

06 Nov 2019 Evaluate

Sun Pharmaceutical Industries is currently trading at Rs. 443.50, up by 13.60 points or 3.16% from its previous closing of Rs. 429.90 on the BSE.

The scrip opened at Rs. 432.00 and has touched a high and low of Rs. 453.00 and Rs. 432.00 respectively. So far 354971 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 603.75 on 09-Nov-2018 and a 52 week low of Rs. 350.40 on 13-May-2019.

Last one week high and low of the scrip stood at Rs. 453.00 and Rs. 424.25 respectively. The current market cap of the company is Rs. 106902.37 crore.

The promoters holding in the company stood at 54.55%, while Institutions and Non-Institutions held 33.23% and 12.23% respectively.

Sun Pharmaceutical Industries has entered into a licensing agreement with AstraZeneca UK (AstraZeneca) to introduce certain novel ready-to-use (RTU) infusion oncology products in China. The agreement will help to bring cost - effective and quality drugs to patients in China.

As per the terms of the agreement, the company will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China. The initial tenure of the agreement is 10 years from the first commercial sale of the said products in China. The financial terms of the agreement are confidential. 

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×